Hospital Universitario 12 de Octubre-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2009

  1. Flow Cytometry Remission Is the Most Relevant Prognostic Factor for MM Patients Who Undergo ASCT

    CLINICAL LYMPHOMA & MYELOMA